Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
暂无分享,去创建一个
Ka Kit Wong | K. Frey | K. Wong | A. Avram | Kirk A Frey | Anca M Avram | John M Cahill | J. Cahill
[1] Holger Amthauer,et al. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT , 2007, Nuclear medicine communications.
[2] R. Bale,et al. Image fusion analysis of 99mTc-HYNIC-Tyr3-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[3] R. Felix,et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours , 2005, European Radiology.
[4] E. P. Krenning,et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients , 1993, European Journal of Nuclear Medicine.
[5] A. Engel,et al. SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours , 2003, Clinical endocrinology.
[6] E P Krenning,et al. Neuroendocrine tumors and somatostatin: imaging techniques. , 2005, Journal of endocrinological investigation.
[7] Frank P DiFilippo,et al. SPECT/CT imaging: clinical utility of an emerging technology. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[8] A. Moreira,et al. Value of SPET/CT image fusion in the assessment of neuroendocrine tumours with 111In-pentetreotide scintigraphy. , 2005, Revista espanola de medicina nuclear.
[9] A. Engel,et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Christopher J. Taylor,et al. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours , 2006 .
[11] C. Claussen,et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[12] P. Erba,et al. Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[13] Nirav P. Shah,et al. Endocrine Neoplasm Scintigraphy: Added Value of Fusing SPECT/CT Images Compared With Traditional Side-by-Side Analysis , 2006, Clinical nuclear medicine.
[14] Richard P Baum,et al. Imaging of neuroendocrine tumors. , 2006, Seminars in nuclear medicine.